| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |